コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ion devices and pulse oximetry values during endotracheal intubation.
2 e together with mechanical ventilation after endotracheal intubation.
3 ts on other outcomes, including the need for endotracheal intubation.
4 ch as non-invasive mechanical ventilation or endotracheal intubation.
5 The primary outcome was endotracheal intubation.
6 rapy for 4 hours or longer before undergoing endotracheal intubation.
7 the most common serious adverse event during endotracheal intubation.
8 R for SARS-CoV-2 requiring ICU admission and endotracheal intubation.
9 nce in patients with marked hypoxemia before endotracheal intubation.
10 Laryngoscopy following endotracheal intubation.
11 edures and requiring general anesthesia with endotracheal intubation.
12 deterioration and death during or soon after endotracheal intubation.
13 function undergoing general anesthesia with endotracheal intubation.
14 s with acute lung injury before the need for endotracheal intubation.
15 was the proportion of patients who required endotracheal intubation.
16 induction and 2 minutes after completion of endotracheal intubation.
17 direct laryngoscopy for the first attempt at endotracheal intubation.
18 uperior to direct laryngoscopy during urgent endotracheal intubation.
19 xposure to postnatal steroids, and prolonged endotracheal intubation.
20 -compromising sequelae in neonates following endotracheal intubation.
21 ry endpoint was the cumulative prevalence of endotracheal intubation.
22 formed on pigs under general anesthesia with endotracheal intubation.
23 Regional anesthesia is preferred to endotracheal intubation.
24 were severe metabolic acidosis and need for endotracheal intubation.
25 y administration of epinephrine, and delayed endotracheal intubation.
26 r patients and families who choose to forego endotracheal intubation.
27 se of NPPV for patients who choose to forego endotracheal intubation.
28 rd against hypoxemia during laryngoscopy and endotracheal intubation.
29 We enrolled 202 consecutive endotracheal intubations.
30 groups were similar with respect to need for endotracheal intubation (14.1% of subjects with intramus
31 outcomes were time from symptom onset to (1) endotracheal intubation, (2) tracheostomy; time from end
32 ertainty) were associated with lower risk of endotracheal intubation (25 studies [3804 patients]).
33 cluded respiratory failure as the reason for endotracheal intubation (4% survival), the presence of p
34 5 minutes [7.0-20.0], P=0.001), led to fewer endotracheal intubations (52% versus 85%, P<0.001), and
36 2, 1.2-4.2), as was the proportion requiring endotracheal intubation (66 of 439 for chlorpyrifos, 15.
37 e survival were significantly lower both for endotracheal intubation (adjusted OR, 0.41; 95% CI, 0.37
38 e survival were significantly lower both for endotracheal intubation (adjusted OR, 0.45; 95% CI, 0.37
39 irway management, including 41,972 (6%) with endotracheal intubation and 239,550 (37%) with use of su
40 understood patients' living wills regarding endotracheal intubation and cardiopulmonary rescuscitati
42 severe acute chest syndrome (ACS) requiring endotracheal intubation and erythrocytopheresis are at i
44 2D patients requiring oxygen administration, endotracheal intubation and ICU admission had significan
46 n-invasive respiratory support alone without endotracheal intubation and mechanical ventilation durin
47 dergo elective surgical procedures requiring endotracheal intubation and mechanical ventilation for a
48 of non-invasive respiratory support without endotracheal intubation and mechanical ventilation incre
49 t initiation of the protocol, ewes underwent endotracheal intubation and mechanical ventilation under
50 tients (23.9%) in the placebo group received endotracheal intubation and mechanical ventilation, comp
52 otal of 489,390 (12.1%) patients experienced endotracheal intubation and mechanical ventilation, with
54 and more effective than administration with endotracheal intubation and mechanical ventilation; howe
56 using NPPV for patients who choose to forego endotracheal intubation and to examine the perspectives
59 6 hours showed a high probability of reduced endotracheal intubation and/or death over a wide range o
60 ess in the future, possibly exceeding 48,000 endotracheal intubations and mechanical ventilation acro
61 on across the country in a month and 100,000 endotracheal intubations and mechanical ventilation in t
62 ber 2020 to January 2021, a total of 104,750 endotracheal intubations and mechanical ventilation occu
63 ntilation), followed by January 2021 (47,100 endotracheal intubations and mechanical ventilation) and
64 with the highest peak in August 2021 (48,735 endotracheal intubations and mechanical ventilation), fo
65 nical ventilation) and December 2021 (43,835 endotracheal intubations and mechanical ventilation).
66 erwent early tracheostomy (within 10 days of endotracheal intubation) and 49 days in those who underw
67 patients and families have decided to forego endotracheal intubation, and 3) NPPV as a palliative mea
70 biotic exposure, presence of a central line, endotracheal intubation, and prior fungal colonization r
71 y develop acute respiratory failure, require endotracheal intubation, and survive to be extubated are
76 lemental oxygen) in neonates undergoing oral endotracheal intubation at two Australian tertiary neona
77 a videolaryngoscope in the ICU on the first endotracheal intubation attempt and intubation-related c
78 2 prespecified secondary outcomes, including endotracheal intubation, barotrauma, skin pressure injur
81 s, clinicians attempt to minimize the use of endotracheal intubation by the early introduction of les
83 sed the number of attempts needed to achieve endotracheal intubation compared with direct laryngoscop
84 Awake prone positioning reduced the risk of endotracheal intubation compared with usual care (crude
86 moglobin level, arterial pH, and presence of endotracheal intubation during hyperbaric treatment.
87 g (intervention group) or after conventional endotracheal intubation during mechanical ventilation (c
88 of patients requiring extended durations of endotracheal intubation during recovery for critical ill
89 continuous NMBA during the first 48 hours of endotracheal intubation (early NMBA) and those without.
90 ts with a diagnosis of achalasia may receive endotracheal intubation (EI) to reduce the risk of aspir
91 need regular clinical experience to perform endotracheal intubation (ETI) in a safe and effective ma
93 vanced airway management with either initial endotracheal intubation (ETI) or initial supraglottic ai
96 rative study of commercial devices to detect endotracheal intubation exists, the syringe device (Tube
99 (control group) within the first 24 h after endotracheal intubation for acute respiratory failure.
100 oronavirus disease 2019 (COVID-19), required endotracheal intubation for at least 7 days, and experie
101 urgical procedures who required single-lumen endotracheal intubation for general anesthesia, hyperang
103 ng the use of invasive central catheters and endotracheal intubation for lower-risk patients, coupled
104 uld be achieved if every UK child who needed endotracheal intubation for more than 12-24 h were admit
105 agmatic trial in which 150 adults undergoing endotracheal intubation in a medical intensive care unit
106 compared with usual care reduces the risk of endotracheal intubation in adults with hypoxemic respira
111 racheostomy is often performed for prolonged endotracheal intubation in critically ill patients.
113 mask is relatively ineffective at preventing endotracheal intubation in patients with acute respirato
114 otension, cardiopulmonary resuscitation, and endotracheal intubation in the catheterization laborator
115 dy included all adult patients who underwent endotracheal intubation in the emergency department or i
116 28 days, 75 of 159 patients (47.2%) required endotracheal intubation in the helmet noninvasive ventil
121 versus attempting an advanced airway such as endotracheal intubation) in patients with out-of-hospita
122 roving to be a well-tolerated alternative to endotracheal intubation, in particular in those patients
123 rsely associated with oxygen administration, endotracheal intubation, intensive care and in-hospital
130 at the main determinants of hypoxemia during endotracheal intubation may be related to critical illne
132 nt therapy or persistent kidney dysfunction, endotracheal intubation, mechanical ventilation days, ex
133 lation, today best applied with sedation and endotracheal intubation, might be considered a prophylac
134 rial (n = 18) compared with those who needed endotracheal intubation (n = 12) (median [interquartile
135 predicting a higher likelihood of difficult endotracheal intubation, no clinical finding reliably ex
136 of benefit with awake prone positioning for endotracheal intubation (non-informative prior, mean rel
140 ase lowest arterial oxygen saturation during endotracheal intubation of critically ill patients compa
144 hanical or cardiopulmonary resuscitation, or endotracheal intubation on the day of the IR procedure.
145 ence was noted in the complication rates for endotracheal intubation or central venous catheterizatio
148 or noninferiority for the primary outcome of endotracheal intubation or death within 7 days in 4 of t
149 the 3 centers, there were no cases requiring endotracheal intubation or resulting in death, neurologi
151 r whether advanced airway management such as endotracheal intubation or use of supraglottic airway de
152 e first serious asthma-related event (death, endotracheal intubation, or hospitalization), as assesse
154 y department diagnosis of organ dysfunction, endotracheal intubation, or systolic blood pressure less
155 single-dose etomidate (H0) for facilitating endotracheal intubation, patients without septic shock w
156 the first-attempt success rate during urgent endotracheal intubation performed by pulmonary and criti
157 omplications were available in all patients: endotracheal intubations, permanent neurologic injuries,
163 ntensive-care-unit (ICU) admission, need for endotracheal intubation, renal replacement therapy and h
164 TICIPANTS: The Supraglottic Airway Device vs Endotracheal intubation (SAVE) trial was a multicenter c
165 reatening hypotension or cardiac arrhythmia, endotracheal intubation, seizure recurrence, and death.
168 ft with laryngeal functional impairment from endotracheal intubation that permanently limits their re
169 ag-mask ventilation, supraglottic airway, or endotracheal intubation), the training and retraining re
171 nterventions stage, and have longer pre-ECMO endotracheal intubation times (P<0.05 for all) than surv
172 nderwent tracheostomy, the average time from endotracheal intubation to tracheostomy was 19.7 days +/
173 racheostomy, 22.76 (8.84; 21) days; and from endotracheal intubation to tracheostomy, 12.23 (6.82; 12
174 heal intubation, (2) tracheostomy; time from endotracheal intubation to tracheostomy; time from trach
177 developed severe episodes of ACS, leading to endotracheal intubation, ventilatory support for respira
181 dergoing mechanical ventilation at baseline, endotracheal intubation was performed in 40 of 222 (18.0
187 inutes' duration with general anesthesia and endotracheal intubation who were admitted to hospital af
188 atients with laryngeal injury resulting from endotracheal intubation who were evaluated at a tertiary
189 n of the 371 critically ill adults requiring endotracheal intubation who were included in the MACMAN
191 hypoxemic respiratory failure who underwent endotracheal intubation with a novel technique combining
192 iteria were age >/=18 years, aneurysmal SAH, endotracheal intubation with mechanical ventilation, and
193 uded the proportion of patients who required endotracheal intubation within 28 days from study enroll
195 ry is a recognized complication of prolonged endotracheal intubation, yet little attention has been p